Mony Chenda Morisse

Adaptation to DNA damage checkpoint in senescent telomerase-negative cells promotes genome instability

Héloïse Coutelier, Zhou Xu, Mony Chenda Morisse et al. · Genes & Development · 2018 · 59 citations · Full text

Prolonged Checkpoint Arrests, Dna Damage, Genetics +18

ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma

Claire Lailler, Christophe Louandre, Mony Chenda Morisse et al. · Bioscience Reports · 2019 · 38 citations · Full text

Immune Microenvironment, Immunology, Biological Microenvironments +17

Squamous Cell Carcinoma Antigen-encoding Genes SERPINB3/B4 as Potentially Useful Markers for the Stratification of HNSCC Tumours

Zuzana Saidak, Mony Chenda Morisse, Denis Chatelain et al. · Anticancer Research · 2018 · 18 citations · Full text

Efficacy and safety of tisagenlecleucel (Tisa-cel) in adult patients (Pts) with relapsed/refractory follicular lymphoma (r/r FL): Primary analysis of the phase 2 Elara trial.

Stephen J. Schuster, Michael Dickinson, Martin Dreyling et al. · Journal of Clinical Oncology · 2021 · 15 citations

Immunology, Immunotherapy, Oncology +19

Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study

Mony Chenda Morisse, Nelly Étienne-Selloum, Diana Bello-Roufai et al. · Journal of Neuro-Oncology · 2019 · 13 citations

Neuro-oncology, Oncology, Multicentric Retrospective Study +9